Xvivo Perfusion AB
XVIVO.ST
#5119
Rank
C$1.77 B
Marketcap
$56.49
Share price
-0.22%
Change (1 day)
68.55%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): C$15.74 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are C$65.99 Million. In 2023 the company made an earning of C$13.11 Million, an increase over its 2022 earnings that were of C$3.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$15.74 M20.04%
2023 C$13.11 M309.49%
2022 C$3.2 M226.49%
2021 C$0.98 M-110.72%
2020 -C$9.16 Million-1221.07%
2019 C$0.81 M-70.61%
2018 C$2.77 M117.32%
2017 C$1.27 M146.09%
2016 C$0.51 M-61.52%
2015 C$1.34 M-3.88%
2014 C$1.4 M-39.59%
2013 C$2.32 M